Beyond CHEK2 GPVs, multiple factors are used to estimate breast cancer risk using programs such as CanRisk, including family history, hormonal and lifestyle factors, breast density, and polygenic risk scores [21]. This evidence concerns the gene CHEK2 and breast carcinoma.